Olfactory vs VNO: Parallel Detection Pathways

Overview

Mammals have two parallel chemosensory systems for detecting chemical signals:

1. Main Olfactory System (MOS): Detects volatile odorants, conscious smell
2. Vomeronasal System (VNS): Detects pheromones, often subconscious

Understanding the differences between these systems explains:

• Why saturated molecules (androsterone) work despite low volatility
• How “unscented” pheromones can have effects
• Why close proximity matters
• The role of both conscious and subconscious detection

Main Olfactory System (MOS)

Structure and Location

The olfactory epithelium is located:

• High in the nasal cavity
• Behind and above the nasal turbinates
• ~10 cm² surface area in humans
• Contains millions of olfactory sensory neurons (OSNs)

Airflow-Dependent Detection

The MOS relies on passive airflow:

1. Inhale air containing volatile compounds
2. Compounds dissolve in nasal mucus
3. Bind to olfactory receptors on cilia
4. Signal transmitted to olfactory bulb
5. Processed in cortex as conscious “smell”

Receptor Diversity

Humans have ~400 functional olfactory receptor (OR) genes:

• Each OSN expresses one receptor type
• Combinatorial coding allows detection of thousands of odorants
• Broad specificity (one receptor can bind multiple similar compounds)

Volatility Requirement

For MOS detection, compounds must:

• Evaporate at body temperature
• Diffuse through air to reach receptors
• Be sufficiently concentrated in inhaled air

Saturation = low volatility = weak MOS detection

Vomeronasal System (VNS)

Structure and Location

The vomeronasal organ (VNO) is:

• Located at the base of the nasal septum
• Bilateral (paired) structures
• Contains a mucus-filled lumen
• Enclosed structure with a narrow duct opening

Active Pumping Mechanism

Unlike the MOS, the VNO uses active pumping:

1. Vascular pump: Blood vessels swell/contract rhythmically
2. Creates suction: Draws fluid from nasal cavity into VNO lumen
3. Mucus transport: Dissolved chemicals reach VNO receptors
4. Non-volatile detection: Airborne diffusion NOT required

This is critical: VNO detection does NOT require volatility.

Receptor Types

The VNO contains two receptor families (in most mammals):

Receptor	G-Protein	Located	Detects
V1R	Gi	Apical zone	Small lipophilic volatiles
V2R	Go	Basal zone	Large non-volatile molecules

V2Rs specifically evolved to detect non-volatile compounds like proteins, peptides, and saturated steroids.

Volatility Independence

The VNO can detect:

• Volatile compounds (V1R pathway)
• Non-volatile compounds (V2R pathway)
• Dissolved steroids in nasal mucus
• Contact-transferred chemicals

Key Differences: MOS vs VNS

Feature	Main Olfactory System	Vomeronasal System
Location	Upper nasal cavity	Base of nasal septum
Structure	Open epithelium	Enclosed organ with duct
Detection mechanism	Passive airflow	Active pumping
Volatility requirement	High (must evaporate)	None (mucus transport)
Receptor families	OR (400 genes)	V1R + V2R
Projection	Olfactory bulb → cortex	Accessory olfactory bulb → amygdala/hypothalamus
Consciousness	Conscious smell	Often subconscious
Function	General odor detection	Pheromone and social chemosignals

Volatile vs Non-Volatile Compounds

Volatility Defined

Volatility = tendency to evaporate at a given temperature

Factors affecting volatility:

1. Molecular weight: Lower = more volatile
2. Double bonds: More = more volatile
3. Hydrogen bonding: Less = more volatile
4. Saturation: Saturated = less volatile

Pheromone Volatility Spectrum

Compound	Double Bonds	Volatility	Primary Pathway
Androstadienone	2 (Δ4,16)	Very high	MOS + V1R
Androstenone	1 (Δ16)	High	MOS + V1R
Androstenol	1 (Δ16)	High	MOS + V1R
Androsterone	0 (saturated)	Very low	V2R (non-volatile)
Androstanediol	0 (saturated)	Very low	V2R (non-volatile)

The Androsterone Paradox

Observation: Androsterone is highly effective as a pheromone Problem: It’s nearly non-volatile (saturated steroid) Old explanation: “Shouldn’t work” or “works through smell” Correct explanation: V2R pathway + VNO pumping mechanism

Androsterone doesn’t need to evaporate - it’s transferred via:

• Nasal mucus contact
• Close-proximity transfer
• VNO active pumping
• Direct V2R activation

Conscious vs Subconscious Detection

Main Olfactory: Conscious

MOS signals project to:

• Olfactory bulb
• Piriform cortex (primary olfactory cortex)
• Orbitofrontal cortex (conscious smell perception)
• Amygdala (emotional associations)

Result: You can consciously smell it

Vomeronasal: Subconscious

VNS signals project to:

• Accessory olfactory bulb
• Amygdala (emotion, threat detection)
• Hypothalamus (hormones, reproduction)
• Medial preoptic area (sexual behavior)

Result: Effects without conscious smell perception

The “Unscented” Phenomenon

Users often report effects from “unscented” pheromone blends. This is explained by:

1. Saturated compounds (androsterone) activate VNS
2. VNS projects to emotional/reproductive centers
3. No activation of conscious smell cortex
4. “No smell” but behavioral/emotional effects present

The VNO Pumping Mechanism

How It Works

The VNO pumping cycle:

Phase 1: Filling

1. Vascular tissue dilates
2. Creates negative pressure (suction)
3. Nasal mucus drawn into VNO lumen
4. Dissolved chemicals contact receptors

Phase 2: Emptying

1. Vascular tissue constricts
2. Creates positive pressure
3. Expels old mucus
4. Prepares for next cycle

Frequency: Every few seconds to minutes (species-dependent)

Implications for Pheromones

The pumping mechanism means:

• Close proximity enhances detection (more mucus transfer)
• Face-to-face conversation optimal (VNO pumping engaged)
• Non-volatile compounds CAN work (mucus transport)
• Contact amplifies effects (direct transfer to nasal mucus)

Human VNO Status

The human VNO is controversial:

• Structure present in most adults
• V1R/V2R genes largely pseudogenized (non-functional)
• Neuronal projections unclear
• Functional capacity debated

Alternative: Cranial Nerve Zero (CN0) may compensate for reduced VNO function.

Detection Modality Combinations

Real-world pheromone detection likely uses both systems:

Androstenone Example

High volatility (Δ16 double bond):

1. MOS pathway: Consciously detected as “musky” or “urinous”
2. V1R pathway: Subconscious pheromone effects
3. Combined: Smell + behavioral response

Androsterone Example

Very low volatility (saturated):

1. MOS pathway: Minimal (not volatile enough)
2. V2R pathway: Strong activation via mucus transfer
3. Result: Effects without conscious smell

Mixed Strategy

Most pheromone blends combine:

• Volatile compounds (androstenone, androstadienone) → MOS + V1R
• Non-volatile compounds (androsterone) → V2R
• Result: Dual pathway activation

Cranial Nerve Zero (CN0) Alternative

Given the uncertain VNO status in humans, CN0 may be the primary pheromone pathway:

Feature	VNO (in other mammals)	CN0 (in humans)
Structure	Enclosed organ	Nerve fibers in nasal epithelium
Receptors	V1R/V2R	Unknown (possibly OR-like)
Projection	Accessory olfactory bulb	Preoptic area, hypothalamus
Function	Pheromone detection	Possibly pheromone modulation

CN0 might:

• Detect pheromones directly
• Modulate MOS signals for pheromone salience
• Work synergistically with MOS

Practical Implications

Application Strategy

Compound Type	Volatility	Application Site	Reasoning
Volatile (androstenone)	High	Chest, neck	Airborne diffusion to MOS
Non-volatile (androsterone)	Low	Jawline, behind ears	Close-proximity mucus transfer
Mixed	Varies	Multiple sites	Cover both pathways

Distance Effects

Distance	MOS Detection	VNS Detection
Several feet	Volatile compounds only	None
1-3 feet	Moderately volatile	Minimal
Face-to-face	All volatiles	Optimal (mucus transfer + pumping)
Contact	All	Maximum (direct transfer)

Why Close Proximity Matters

For non-volatile pheromones (androsterone, androstanediol):

1. Must transfer to partner’s nasal mucus
2. VNO pumping draws dissolved compound into lumen
3. V2R receptors activated
4. Behavioral/emotional effects

Distance = reduced transfer = reduced effects

Myth-Busting

Myth 1: “Pheromones must be volatile”

Reality: V2R pathway specifically detects non-volatile compounds via VNO pumping.

Myth 2: “If you can’t smell it, it’s not working”

Reality: VNS-mediated effects are often subconscious (no smell perception).

Myth 3: “Human VNO is vestigial, so pheromones don’t work”

Reality: CN0 may compensate, and MOS can detect some pheromones directly.

Myth 4: “Saturation means ineffective”

Reality: Saturated steroids use mucus-mediated transfer, not airborne diffusion.

Research Evidence

V2R and Non-Volatile Detection

Leinders-Zufall et al. (2000) showed:

• V2Rs respond to peptides and proteins
• No volatility requirement
• Mucus transport sufficient

MOS Pheromone Detection

Savic et al. (2001) demonstrated:

• Androstadienone activates hypothalamus via MOS
• Sex-differentiated responses
• MOS can mediate pheromone effects even without VNO

VNO Pumping

Meredith & O’Connell (1979):

• VNO pumping measured in hamsters
• Rhythmic vascular contractions confirmed
• Essential for non-volatile detection

Evolutionary Perspective

Mammals: Dual System

Most mammals retain:

• Functional MOS (all odorants)
• Functional VNS (pheromones, especially non-volatile)

Primates: VNS Reduction

Primates (especially humans):

• MOS remains fully functional
• VNS reduced or altered
• CN0 may have expanded role
• Greater reliance on visual/auditory signals

Human Adaptation

Humans likely use:

• MOS for volatile pheromone detection
• CN0 for pheromone modulation or detection
• Cognitive processing for social chemosignals

Key Takeaways

1. MOS detects volatiles via airflow, VNS detects via active pumping
2. VNO can detect non-volatile compounds (V2R pathway)
3. Volatility is NOT required for pheromone activity
4. Androsterone efficacy explained by V2R/mucus transport
5. Close proximity enhances non-volatile detection
6. “Unscented” effects are real (subconscious VNS pathway)
7. Both systems likely work together in humans
8. CN0 may compensate for reduced human VNO function

Scientific Confidence

Confidence Level: High (for general mammalian systems) Confidence Level: Medium (for human-specific mechanisms)

The MOS and VNS are well-characterized in mammals. The VNO pumping mechanism is confirmed. V2R detection of non-volatile compounds is established.

The uncertainty is in human-specific pathways - the relative roles of VNO, CN0, and MOS in human pheromone detection remain active research areas.